Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bernard

Showing results (711-720 of 721) with videos related to

Pageof 73
Sort By:
Nature|September 28, 2017
Massively parallel de novo protein design for targeted therapeuticsAaron Chevalier, Daniel-Adriano Silva, Gabriel J Rocklin, et al.
Journal of Medicinal Chemistry|September 18, 2025
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High CancersShota Kikuchi, Jason C Green, Don C Rogness, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Science (New York, N.Y.)|November 3, 2018
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutininNick S Laursen, Robert H E Friesen, Xueyong Zhu, et al.
Journal of Endocrinological Investigation|June 1, 2020
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre studyP Perros, M P Žarković, G C Panagiotou, et al.
Science (New York, N.Y.)|October 9, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Nature|April 24, 2024
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Cancer Discovery|December 19, 2025
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growthNilotpal Roy, Tine Wyseure, I-Chung Lo, et al.
Translational Psychiatry|March 30, 2016
Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis ConsortiumS Stringer, C C Minică, K J H Verweij, et al.
Pageof 73

Showing results (711-720 of 721) with videos related to

Sort By:
Pageof 73
Nature|September 28, 2017
Massively parallel de novo protein design for targeted therapeuticsAaron Chevalier, Daniel-Adriano Silva, Gabriel J Rocklin, et al.
Journal of Medicinal Chemistry|September 18, 2025
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High CancersShota Kikuchi, Jason C Green, Don C Rogness, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Science (New York, N.Y.)|November 3, 2018
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutininNick S Laursen, Robert H E Friesen, Xueyong Zhu, et al.
Journal of Endocrinological Investigation|June 1, 2020
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre studyP Perros, M P Žarković, G C Panagiotou, et al.
Science (New York, N.Y.)|October 9, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Nature|April 24, 2024
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Cancer Discovery|December 19, 2025
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growthNilotpal Roy, Tine Wyseure, I-Chung Lo, et al.
Translational Psychiatry|March 30, 2016
Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis ConsortiumS Stringer, C C Minică, K J H Verweij, et al.
Pageof 73